Durect Merges with Bausch Health, Delists from Nasdaq
I'm PortAI, I can summarize articles.
Durect Corporation has merged with Bausch Health Americas, becoming a wholly owned subsidiary and delisting from Nasdaq. The merger, completed on September 11, 2025, did not require a stockholder vote and resulted in a new board structure. Analysts rate Durect stock (DRRX) as a Hold with a $2.00 price target, while Spark's AI Analyst considers it Neutral due to financial challenges and unattractive valuation. The merger presents strategic benefits but carries risks, including Nasdaq delisting.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments